Table 3.
N | Univariate analyses | Multivariate analyses† | |||
---|---|---|---|---|---|
Presence of DELC | Presence of DELC | ||||
OR (95% CI) | P-value | OR (95% CI) | P-value | ||
WMH−/Aβ− group | 57 | Reference | Reference | ||
WMH−/Aβ+ group | 137 | 2.39 (1.24–4.61) | 0.010 | 2.94 (1.39–6.20) | 0.005 |
WMH+/Aβ− group | 150 | 4.31 (2.23–8.32) | <0.001 | 3.29 (1.59–6.82) | 0.001 |
WMH+/Aβ+ group | 127 | 7.29 (3.63–14.63) | <0.001 | 7.32 (3.35–16.01) | <0.001 |
†Multivariate logistic regression analyses were performed after adjusting for age, sex, hypertension, diabetes mellitus, hyperlipidemia, history of stroke and ischemic heart disease, and APOE ε4 status.
Abbreviations: WMH = white matter hyperintensities; Aβ = amyloid-beta; DELC = diagonal earlobe crease; OR = odds ratio; CI = confidence interval; N = number; APOE = apolipoprotein E; WMH−/Aβ− = patients with minimal WMH and Aβ-negative; WMH−/Aβ+ = patients with minimal WMH and Aβ-positive; WMH+/Aβ− = patients with moderate to severe WMH and Aβ-negative; WMH+/Aβ+ = patients with moderate to severe WMH and Aβ-positive.